These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3110766

  • 1. [Characteristics of a Mycobacterium population growing in pulmonary tuberculomas].
    Dorozhkov IR, Karachunskiĭ MA, Kiazimova LG.
    Probl Tuberk; 1987; (4):46-50. PubMed ID: 3110766
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of rifampicin on the L transformation of a mycobacterial population in patients with destructive pulmonary tuberculosis].
    Karachunskiĭ MA, Dorozhkova IR, Chukanov VI, Balta IuE, Kiazimova LM.
    Probl Tuberk; 1986; (9):31-4. PubMed ID: 3097632
    [No Abstract] [Full Text] [Related]

  • 3. [L forms of Mycobacterium tuberculosis and their clinico-epidemiological significance].
    Anastasatu C, Moldovan O.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(3):203-13. PubMed ID: 3001898
    [No Abstract] [Full Text] [Related]

  • 4. [Characteristics of the course of destructive pulmonary tuberculosis with L-forms of mycobacteria in the sputum].
    Golanov VS.
    Vrach Delo; 1981 Aug; (8):79-81. PubMed ID: 6791384
    [No Abstract] [Full Text] [Related]

  • 5. [Mycobacterium tuberculosis L forms in patients with abacillary lung caverns].
    Berezovskiĭ BA, Golanov VS.
    Probl Tuberk; 1981 Jun; (6):22-5. PubMed ID: 6792625
    [No Abstract] [Full Text] [Related]

  • 6. [Characteristics of bacterial discharge in patients with different forms of pulmonary tuberculosis].
    Golanov VS, Andreev LP, Bogdalova VE, Meshcheriakov VG, Ushakova AG, Bondin SV.
    Probl Tuberk; 1994 Jun; (5):43-5. PubMed ID: 7870727
    [Abstract] [Full Text] [Related]

  • 7. [Importance of microbiological research in correcting the antibacterial therapy of tuberculosis].
    Dolzhanskiĭ VM, Sagalovich VIa.
    Ter Arkh; 1987 Jun; 59(7):77-80. PubMed ID: 3118492
    [Abstract] [Full Text] [Related]

  • 8. [L-forms of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis].
    Karachunskiĭ MA, Dorozhkova IR, Kaminskaia AA, Abdullaeva ET.
    Probl Tuberk; 1983 Jul; (7):38-43. PubMed ID: 6415651
    [No Abstract] [Full Text] [Related]

  • 9. [Increasing the effectiveness of microbiological diagnosis of limited nondestructive pulmonary tuberculosis].
    Gamzaeva NF, Dorozhkova IR, Karachunskiĭ MA.
    Probl Tuberk; 1989 Jul; (2):55-7. PubMed ID: 2495528
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical significance of drug resistance of tuberculosis mycobacteria and L-forms].
    Golanov VS, Bogdalova VE, Andreev LP, Losin EI, Ushakova AG, Meshcheriakov VG, Bondin SV.
    Probl Tuberk; 1991 Jul; (12):27-8. PubMed ID: 1803368
    [Abstract] [Full Text] [Related]

  • 11. [Quantitative and qualitative characteristics of bacterial excretion in socially maladapted patients with pulmonary tuberculosis and outcomes of the process].
    Bondin SV.
    Probl Tuberk; 1992 Jul; (3-4):51-3. PubMed ID: 1528836
    [Abstract] [Full Text] [Related]

  • 12. [Mycobacterium tuberculosis L forms in patients with pulmonary and pleural tuberculosis during antibacterial chemotherapy].
    Osiĭskiĭ IIu, Kotliar KD.
    Vrach Delo; 1989 Sep; (9):55-6. PubMed ID: 2514488
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical significance of finding mycobacterial L forms in patients with destructive pulmonary tuberculosis].
    Golanov VS.
    Probl Tuberk; 1986 Sep; (9):25-8. PubMed ID: 3097630
    [No Abstract] [Full Text] [Related]

  • 14. [L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis].
    Khomenko AG, Karachunskiĭ MA, Dorozhkova IR, Chukanov VI, Balta IuE.
    Probl Tuberk; 1980 Feb; (2):18-23. PubMed ID: 6769110
    [No Abstract] [Full Text] [Related]

  • 15. [Comparative characteristics of disseminated pulmonary tuberculosis in patients isolating Mycobacterium tuberculosis with a high and low viability].
    Koretskaia NM, Iarygina IV.
    Probl Tuberk Bolezn Legk; 2007 Feb; (2):17-20. PubMed ID: 17419328
    [Abstract] [Full Text] [Related]

  • 16. [Studies on the origin and clinical significance of smear-positive and culture-negative tubercle bacilli].
    Tsukamura M, Toyama H.
    Kekkaku; 1984 Aug; 59(8):451-9. PubMed ID: 6438383
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical picture and course of chronic destructive pulmonary tuberculosis in patients secreting L forms of the causative agent].
    Karachunskiĭ MA, Dorozhkova IR, Abdullaeva ET.
    Probl Tuberk; 1985 Aug; (12):13-6. PubMed ID: 3938018
    [No Abstract] [Full Text] [Related]

  • 18. [Characteristics of qualitative changes in the Mycobacteria population during the treatment of middle-aged and elderly patients with newly detected pulmonary tuberculosis].
    Dorozhkova IR, Karachunskiĭ MA, Kochetkova EIa.
    Probl Tuberk; 1990 Aug; (4):7-11. PubMed ID: 2118647
    [Abstract] [Full Text] [Related]

  • 19. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
    Protsiuk RG.
    Probl Tuberk; 1983 May; (5):38-42. PubMed ID: 6408637
    [No Abstract] [Full Text] [Related]

  • 20. [Evaluation of the extent of massive bacterial elimination in newly detected patients with destructive pulmonary tuberculosis].
    Roslik SM, Pashkov IuN, Pashkova TV.
    Vrach Delo; 1988 Oct; (10):39-40. PubMed ID: 3146162
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.